Ewald Auer

Director, Neuropharmacology at QPS

Ewald Auer is an experienced professional in business development, currently serving as the Business Development Director at Scantox Group since April 2024 and has been with QPS Austria GmbH since November 2008, where roles have included Director of Business Development and Research Associate. Ewald Auer earned a Master's degree in Molecular Biology from the University of Graz, completing studies between 2000 and 2008.

Location

Obervogau, Austria

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


QPS

QPS is a GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug development services. An award-winning leader focused on bioanalytics and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction and turnkey laboratories and facilities. We are passionate about our work, creating value for patients and customers while generating opportunities for employees to thrive.